DDInter948 DDInter21
Human interferon beta (165 residues), cysteine 17 is substituted with serine. Produced in E. coli, no carbohydrates, MW=18.5kD
An oral retinoid effective in the treatment of psoriasis. It is the major metabolite of etretinate with the advantage of a much shorter half-life when compared with etretinate.
Acitretin {u} (Compound) resembles {v} (Compound) Vitamin A
Acitretin {u} may lead to a major life threatening interaction when taken with {v} Isotretinoin
Acitretin {u} (Compound) treats {v} (Disease) psoriasis
Acitretin {u} (Compound) binds {v} (Gene) RBP1
Acitretin {u} (Compound) upregulates {v} (Gene) RAP1GAP
Acitretin {u} (Compound) is included by {v} (Pharmacologic Class) Retinoids
Acitretin {u} (Compound) downregulates {v} (Gene) DNAJA3
Acitretin {u} (Compound) causes {v} (Side Effect) Optic neuritis
Acitretin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Asparaginase Erwinia chrysanthemi
Acitretin {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Interferon beta-1a
Acitretin (Compound) resembles Vitamin A (Compound)
Acitretin may lead to a major life threatening interaction when taken with Isotretinoin
Acitretin (Compound) treats psoriasis (Disease)
Acitretin (Compound) binds RBP1 (Gene)
Acitretin (Compound) upregulates RAP1GAP (Gene)
Acitretin (Compound) is included by Retinoids (Pharmacologic Class)
Acitretin (Compound) downregulates DNAJA3 (Gene)
Acitretin (Compound) causes Optic neuritis (Side Effect)
Acitretin may cause a moderate interaction that could exacerbate diseases when taken with Asparaginase Erwinia chrysanthemi
Acitretin may cause a moderate interaction that could exacerbate diseases when taken with Interferon beta-1a